EGF Relays Signals to COP1 and Facilitates FOXO4 Degradation to Promote Tumorigenesis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGF Relays Signals to COP1 and Facilitates FOXO4 Degradation to Promote Tumorigenesis
Authors
Keywords
-
Journal
Advanced Science
Volume 7, Issue 20, Pages 2000681
Publisher
Wiley
Online
2020-09-23
DOI
10.1002/advs.202000681
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer
- (2019) Kai Li et al. CELL RESEARCH
- The Intestinal Microbiota in Colorectal Cancer
- (2018) Herbert Tilg et al. CANCER CELL
- SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer
- (2018) Ankit Malik et al. IMMUNITY
- Forkhead box O4 transcription factor in human neoplasms: Cannot afford to lose the novel suppressor
- (2018) Chenxi Lu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dysbiosis of gut microbiota in promoting the development of colorectal cancer
- (2017) Shaomin Zou et al. Gastroenterology Report
- Serine Metabolism Links Tumor Suppression to the Epigenetic Landscape
- (2016) Xia Gao et al. Cell Metabolism
- LKB1 loss links serine metabolism to DNA methylation and tumorigenesis
- (2016) Filippos Kottakis et al. NATURE
- A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
- (2016) Michael E Pacold et al. Nature Chemical Biology
- ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development
- (2015) Lekun Fang et al. CANCER CELL
- Regulating the stability and localization of CDK inhibitor p27Kip1via CSN6-COP1 axis
- (2015) Hyun Ho Choi et al. CELL CYCLE
- CSN6 deregulation impairs genome integrity in a COP1-dependent pathway
- (2015) Hyun Ho Choi et al. Oncotarget
- Characterization of the Usage of the Serine Metabolic Network in Human Cancer
- (2014) Mahya Mehrmohamadi et al. Cell Reports
- CDK inhibitor p57Kip2is downregulated by Akt during HER2-mediated tumorigenicity
- (2013) Ruiying Zhao et al. CELL CYCLE
- FOXOs: signalling integrators for homeostasis maintenance
- (2013) Astrid Eijkelenboom et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cancer genetics and genomics of human FOX family genes
- (2012) Masuko Katoh et al. CANCER LETTERS
- HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53
- (2012) Yuwen Xue et al. CELL CYCLE
- Regulation of FOXO protein stability via ubiquitination and proteasome degradation
- (2011) Haojie Huang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Good COP1 or bad COP1? In vivo veritas
- (2011) Wenyi Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers
- (2011) Ruiying Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice
- (2011) Domenico Migliorini et al. JOURNAL OF CLINICAL INVESTIGATION
- COP1 is a tumour suppressor that causes degradation of ETS transcription factors
- (2011) Alberto C. Vitari et al. NATURE
- COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ
- (2011) H H Choi et al. ONCOGENE
- MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation
- (2009) Wei Fu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1
- (2009) D.-Q. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mdm2 Induces Mono-Ubiquitination of FOXO4
- (2008) Arjan B. Brenkman et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started